Renal Division, University Hospital, 185 De Pintelaan, 9000 Gent, Belgium.
Nat Rev Nephrol. 2010 Feb;6(2):75-82. doi: 10.1038/nrneph.2009.210. Epub 2009 Dec 15.
In 2008, an estimated 1.77 million patients worldwide received dialysis. Of these patients, 1.58 million were treated with hemodialysis and approximately 190,000 received peritoneal dialyisis. In a global comparison of treatment methods for renal failure, therefore, hemodialysis clearly dominates. In this Review, we compare the epidemiology of peritoneal dialysis with that of hemodialysis and describe some of the major differences in the global utilization of the two dialysis modalities. These differences can largely be explained by a number of nonmedical, mainly economic factors, but also by educational and psychological factors. To reverse the current trends, the implementation of suitable reimbursement strategies for peritoneal dialysis is needed as well as increased investment in the training of young nephrology fellows and in education programs for patients and other non-nephrological health-care providers. To achieve these goals, academic and nonacademic training centers, which often consider peritoneal dialysis to be a low-level priority, must invest in research and training related to peritoneal dialysis.
2008 年,全球约有 177 万患者接受透析治疗。在这些患者中,158 万人接受血液透析治疗,约 19 万人接受腹膜透析治疗。因此,在全球范围内对肾衰竭的治疗方法进行比较时,血液透析显然占据主导地位。在本篇综述中,我们比较了腹膜透析与血液透析的流行病学,并描述了两种透析方式在全球应用中的一些主要差异。这些差异在很大程度上可以用许多非医学因素(主要是经济因素)来解释,同时也可以用教育和心理因素来解释。为了扭转当前的趋势,需要为腹膜透析实施适当的报销策略,并增加对年轻肾病学研究员的培训以及对患者和其他非肾病学医疗保健提供者的教育计划的投资。为了实现这些目标,往往将腹膜透析视为低优先级的学术和非学术培训中心必须投资于与腹膜透析相关的研究和培训。